Ziad Fayad, MD
Vascular Surgery · Mishawaka, INNPI 1508025867
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (53.2%), food and beverage and education — rather than concentrated in one kind of arrangement. 24 manufacturers reported payments, led by W. L. Gore & Associates, Inc. at 30.9% of the total. Reporting peaked in 2019 at $5,805 and has fallen 70.6% since, to $1,708 in 2025.
Across 134 payments — averaging $88.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- W. L. Gore & Associates, Inc.$4K
- Endologix LLC$4K
- Bolton Medical Inc$888
- Philips North America LLC$754
- Cook Medical LLC$689
- Siemens Medical Solutions USA, Inc.$595
- plus $2K from 18 others
What the payments were for
- Travel & lodging$6,32453%
- Food & beverage$5,38045%
- Education$1832%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| W. L. Gore & Associates, Inc. | 28 | $3,671 |
| Endologix LLC | 23 | $3,515 |
| Bolton Medical Inc | 7 | $888 |
| Philips North America LLC | 7 | $754 |
| Cook Medical LLC | 12 | $689 |
| Siemens Medical Solutions USA, Inc. | 3 | $595 |
| Johnson & Johnson(2 entities) | 22 | $407 |
| Veryan Medical Incorporated | 2 | $240 |
| Terumo Medical Corporation | 4 | $158 |
| Shockwave Medical, Inc | 5 | $140 |
| Medical Device Business Services, Inc. | 1 | $137 |
| Boston Scientific | 1 | $136 |
| Janssen Scientific Affairs, LLC | 1 | $111 |
| Penumbra, Inc. | 3 | $84 |
| Novartis | 3 | $71 |
| Lemaitre Vascular, Inc. | 2 | $60 |
| Angiodynamics, Inc. | 2 | $59 |
| Silk Road Medical, Inc. | 2 | $45 |
| Medtronic | 1 | $41 |
| Cvrx, Inc. | 1 | $20 |
| Convatec Inc. | 1 | $18 |
| Shire North American Group Inc | 1 | $18 |
| Clinical Technology, Inc | 1 | $14 |
| Cardiovascular Systems Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AFX$1,900
- Ovation$1,416
- TAG Thoracic Endoprosthesis$912
- GORE TAG Thoracic Branch Endoprosthesis$869
- Azurion 7 M20$600
- Artis pheno$558
- TREO ABDOMINAL STENT-GRAFT SYSTEM$542
- GORE TAG Thoracic Endoprosthesis$501
- GORE EXCLUDER Thoracoabdominal Branch Endoprosthesis$458
- Cook Medical Zenith$370
- BioMimics 3D Vascular Stent System$240
- Conformable TAG Thoracic Endoprosthesis$188
- STRATAFIX$137
- WATCHMAN Access System$136
- EXCLUDER Iliac Branch Endoprosthesis$121
- XARELTO$111
- Azur CX Detachable$109
- GORE TAG Conformable Thoracic Endoprosthesis$104
How this compares
$11,886 in reported general payments places this provider in the 75th percentile of 71 vascular surgery providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 50 | $64,928 |
| EliquisApixaban | 19 | $26,242 |
| Varenicline Tartrate | 35 | $5,916 |
| ClopidogrelClopidogrel Bisulfate | 359 | $2,905 |
| Atorvastatin Calcium | 239 | $1,807 |
| Cilostazol | 32 | $1,056 |
| Rosuvastatin Calcium | 59 | $503 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 20 | $55 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 18 | $36 |
| Prednisone | 12 | $15 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $407 | $64,92850 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 71 vascular surgery providers in Indiana.
Other vascular surgery in Mishawaka
- Luis GomezMishawaka$52K
- Michael ShaoFort Wayne$155K
- Sajjad HussainIndianapolis$109K
- Ricardo VasquezBloomington$82K
- Andres FajardoIndianapolis$58K
- Angela MartinEvansville$54K
- Matthew LangenbergEvansville$36K
- Brandon DowningIndianapolis$33K
- Deepak GuttikondaIndianapolis$33K
- Jeffrey WeinbergerIndianapolis$20K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.